JPH0527461Y2 - - Google Patents
Info
- Publication number
- JPH0527461Y2 JPH0527461Y2 JP3988988U JP3988988U JPH0527461Y2 JP H0527461 Y2 JPH0527461 Y2 JP H0527461Y2 JP 3988988 U JP3988988 U JP 3988988U JP 3988988 U JP3988988 U JP 3988988U JP H0527461 Y2 JPH0527461 Y2 JP H0527461Y2
- Authority
- JP
- Japan
- Prior art keywords
- surrounding
- ointment
- eye
- king
- potassium hydroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 42
- 238000011282 treatment Methods 0.000 claims description 23
- 241000287828 Gallus gallus Species 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000002674 ointment Substances 0.000 claims description 13
- 239000000853 adhesive Substances 0.000 claims description 7
- 230000001070 adhesive effect Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 208000003643 Callosities Diseases 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229920013716 polyethylene resin Polymers 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000012030 stroop test Methods 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 1
- 229920002675 Polyoxyl Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3988988U JPH0527461Y2 (enrdf_load_stackoverflow) | 1988-03-26 | 1988-03-26 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3988988U JPH0527461Y2 (enrdf_load_stackoverflow) | 1988-03-26 | 1988-03-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01142416U JPH01142416U (enrdf_load_stackoverflow) | 1989-09-29 |
| JPH0527461Y2 true JPH0527461Y2 (enrdf_load_stackoverflow) | 1993-07-13 |
Family
ID=31266374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3988988U Expired - Lifetime JPH0527461Y2 (enrdf_load_stackoverflow) | 1988-03-26 | 1988-03-26 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0527461Y2 (enrdf_load_stackoverflow) |
-
1988
- 1988-03-26 JP JP3988988U patent/JPH0527461Y2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01142416U (enrdf_load_stackoverflow) | 1989-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5415866A (en) | Topical drug delivery system | |
| US5538740A (en) | Therapeutic and cosmetic compositions for treatment of skin | |
| US3814095A (en) | Occlusively applied anesthetic patch | |
| KR20030009385A (ko) | 국소 마취제의 국소 투여를 위한 피내 침투제 | |
| US4788061A (en) | Extended occlusive treatment of skin disorders | |
| EP0531495B1 (en) | Therapeutic and cosmetic compositions for treatment of skin | |
| JP2020529392A (ja) | 傷痕の予防または治療のための組成物 | |
| CA2883455C (en) | Improved wound healing compositions comprising microspheres | |
| ES2251623T3 (es) | Dispositivo de cuidado de heridas. | |
| KR20100005091U (ko) | 뜸 기능을 갖는 자기 경혈 패치 | |
| JPH0527461Y2 (enrdf_load_stackoverflow) | ||
| Burzotta et al. | Phenol and alcohol chemical matrixectomy | |
| CN1268357C (zh) | 一种治疗疖、疽、痈、疔毒及烧烫伤的药物组合物 | |
| RU2005488C1 (ru) | Средство для лечения болезней соединительной ткани | |
| US6011061A (en) | Therapeutic methods and preparations using rubidium ions | |
| US3200037A (en) | Topic angiotonic compositions | |
| US20240050361A1 (en) | Topical product hands-free applicator drug delivery system and methods of making and using the same | |
| US4476115A (en) | Analgesic composition and method of treating subdermal pain | |
| Knight | Medical management of pressure sores | |
| JPH08500343A (ja) | セシウムイオンを用いた治療方法 | |
| EP0525267A2 (en) | Prolonged occlusion treatment system | |
| RU2266743C2 (ru) | Способ лечения онихомикозов комбинированным препаратом | |
| EP3173066A1 (en) | Plaster comprising antiedematous substances for the treatment of bruising and injury | |
| Spigel | Opportunistic cutaneous myiasis | |
| JP2008044916A (ja) | 褥瘡治療薬 |